Loss of full-length hnRNP R isoform impairs DNA damage response in motoneurons by inhibiting Yb1 recruitment to chromatin.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
02 12 2021
Historique:
accepted: 28 10 2021
revised: 20 10 2021
received: 13 11 2020
pubmed: 2 12 2021
medline: 11 1 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

Neurons critically rely on the functions of RNA-binding proteins to maintain their polarity and resistance to neurotoxic stress. HnRNP R has a diverse range of post-transcriptional regulatory functions and is important for neuronal development by regulating axon growth. Hnrnpr pre-mRNA undergoes alternative splicing giving rise to a full-length protein and a shorter isoform lacking its N-terminal acidic domain. To investigate functions selectively associated with the full-length hnRNP R isoform, we generated a Hnrnpr knockout mouse (Hnrnprtm1a/tm1a) in which expression of full-length hnRNP R was abolished while production of the truncated hnRNP R isoform was retained. Motoneurons cultured from Hnrnprtm1a/tm1a mice did not show any axonal growth defects but exhibited enhanced accumulation of double-strand breaks and an impaired DNA damage response upon exposure to genotoxic agents. Proteomic analysis of the hnRNP R interactome revealed the multifunctional protein Yb1 as a top interactor. Yb1-depleted motoneurons were defective in DNA damage repair. We show that Yb1 is recruited to chromatin upon DNA damage where it interacts with γ-H2AX, a mechanism that is dependent on full-length hnRNP R. Our findings thus suggest a novel role of hnRNP R in maintaining genomic integrity and highlight the function of its N-terminal acidic domain in this context.

Identifiants

pubmed: 34850154
pii: 6439689
doi: 10.1093/nar/gkab1120
pmc: PMC8643683
doi:

Substances chimiques

Chromatin 0
Heterogeneous-Nuclear Ribonucleoproteins 0
Hnrpr protein, mouse 0
Protein Isoforms 0
Y-Box-Binding Protein 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12284-12305

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2859-E2868
pubmed: 29507242
Cell. 2015 Oct 22;163(3):712-23
pubmed: 26496610
Nature. 2011 Jun 15;474(7351):337-42
pubmed: 21677750
Nucleic Acids Res. 2004 Jan 12;32(1):316-27
pubmed: 14718551
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
EMBO J. 2001 Oct 1;20(19):5443-52
pubmed: 11574476
Mol Cell Biol. 1997 Apr;17(4):1776-86
pubmed: 9121425
Int J Biochem Cell Biol. 2006;38(8):1300-13
pubmed: 16584908
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Mol Cell Proteomics. 2006 Jun;5(6):1033-44
pubmed: 16522924
J Cell Biol. 2003 Nov 24;163(4):801-12
pubmed: 14623865
Cell Rep. 2012 Feb 23;1(2):167-78
pubmed: 22574288
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4696-4705
pubmed: 30770445
Aging (Albany NY). 2019 Sep 16;11(18):7473-7491
pubmed: 31527303
Wiley Interdiscip Rev RNA. 2014 Jan-Feb;5(1):95-110
pubmed: 24217978
Nat Commun. 2021 Feb 24;12(1):1278
pubmed: 33627647
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17809-14
pubmed: 25453086
Hum Genet. 2016 Aug;135(8):851-67
pubmed: 27215579
Curr Neuropharmacol. 2019;17(12):1146-1157
pubmed: 31362659
Redox Biol. 2014 Jan 09;2:457-65
pubmed: 24624335
Biochem J. 2010 Sep 15;430(3):379-92
pubmed: 20795951
Acta Neuropathol Commun. 2019 Feb 12;7(1):18
pubmed: 30755280
Mol Cell Proteomics. 2014 Dec;13(12):3410-20
pubmed: 25193168
Sci Rep. 2018 Jun 8;8(1):8755
pubmed: 29884807
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D535-9
pubmed: 16381927
Biochim Biophys Acta. 2016 Oct;1862(10):2004-14
pubmed: 27460707
Cell Mol Biol Lett. 2008;13(2):303-11
pubmed: 18197392
Biochim Biophys Acta. 2016 Dec;1864(12):1631-1640
pubmed: 27544639
Hum Mol Genet. 2002 Jan 1;11(1):93-105
pubmed: 11773003
BMC Res Notes. 2009 Dec 10;2:243
pubmed: 20003239
Wiley Interdiscip Rev RNA. 2016 Mar-Apr;7(2):227-40
pubmed: 26708421
Nat Protoc. 2010 Jan;5(1):31-8
pubmed: 20057379
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Nucleic Acids Res. 2018 Sep 19;46(16):8326-8346
pubmed: 30010942
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Biochemistry (Mosc). 2015 Feb;80(2):219-27
pubmed: 25756536
J Proteome Res. 2010 Feb 5;9(2):1104-20
pubmed: 20020773
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
RNA. 2013 May;19(5):591-604
pubmed: 23474544
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2347-E2356
pubmed: 28270613
Cell Calcium. 2008 Oct;44(4):386-99
pubmed: 19230142
Trends Biochem Sci. 2014 Mar;39(3):141-9
pubmed: 24534650
Cell Cycle. 2013 Dec 15;12(24):3791-803
pubmed: 24107631
PLoS One. 2014 Oct 22;9(10):e110846
pubmed: 25338097
Nat Protoc. 2006;1(1):23-9
pubmed: 17406208
Annu Rev Biochem. 2011;80:273-99
pubmed: 21548781
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
pubmed: 11309499
Nat Commun. 2018 Sep 11;9(1):3683
pubmed: 30206235
RNA Biol. 2009 Jan-Mar;6(1):59-64
pubmed: 19098458
J Proteome Res. 2010 Mar 5;9(3):1402-15
pubmed: 20000738
Nat Commun. 2018 Jan 23;9(1):335
pubmed: 29362359
Oncotarget. 2018 May 4;9(34):23349-23365
pubmed: 29805738
Am J Hum Genet. 2019 Jun 6;104(6):1040-1059
pubmed: 31079900
J Biol Chem. 2009 Aug 28;284(35):23472-80
pubmed: 19581295
J Immunol. 2016 Jun 15;196(12):4967-76
pubmed: 27194785
Hum Mol Genet. 2010 May 15;19(10):1951-66
pubmed: 20167579
Nucleic Acids Res. 1998 Jan 15;26(2):439-45
pubmed: 9421497
Dev Dyn. 1992 Jul;194(3):209-21
pubmed: 1467557

Auteurs

Hanaa Ghanawi (H)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Luisa Hennlein (L)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Abdolhossein Zare (A)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Jakob Bader (J)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried82152, Germany.

Saeede Salehi (S)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Daniel Hornburg (D)

Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.

Changhe Ji (C)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Rajeeve Sivadasan (R)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Carsten Drepper (C)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Felix Meissner (F)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried82152, Germany.
Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.

Matthias Mann (M)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried82152, Germany.
NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.

Sibylle Jablonka (S)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Michael Briese (M)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Michael Sendtner (M)

Institute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg 97080, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH